2021 American Transplant Congress
Donor Derived Cell-free-dna (dd-cfdna) as a Surrogate Marker for Kidney Biopsy- Indiana University Transplant Nephrology Experience
*Purpose: Patient monitoring after kidney transplantation (KT) for early detection of allograft rejection remains key in preventing allograft loss. Donor-derived cell-free DNA (dd-cfDNA), a noninvasive…2021 American Transplant Congress
Impact of Valganciclovir Prophylaxis Dosing in High Risk Cytomegalovirus Kidney and Pancreas Transplant Recipients with Delayed Graft Function
*Purpose: We sought to compare outcomes of cytomegalovirus (CMV) prophylaxis in high risk CMV (donor +/recipient -) kidney and pancreas transplant recipients who received different…2021 American Transplant Congress
Impact of Early versus Late Ureteric Stent Removal and Antibiotic Prophylaxis on Urinary Tract Infection Incidence in Kidney Transplant Adult Recipients
*Purpose: To investigate the impact of early Vs. late ureteric stent removal while utilizing various antibiotic prophylaxis regimens on UTI in renal transplant recipients. *Methods:…2021 American Transplant Congress
Risk Factors Associated with Multidrug Resistant Organism (MDRO) Infections in Kidney Transplant Recipients: A Single Center Experience
*Purpose: Risk factors for MDRO infections in kidney transplant recipients have previously been studied but limited to urinary tract infections. We sought to evaluate the…2021 American Transplant Congress
HLA Haplotype Frequency and Racial Disparities in Access to Transplant Among Highly Sensitized Kidney Transplant Candidates
*Purpose: Despite implementation of the Kidney Allocation System (KAS) which prioritizes sensitized patients, sensitized Black individuals are less likely to receive a transplant than non-Black…2021 American Transplant Congress
The Implications of Donor-Recipient Size Mismatch in Renal Transplantation
*Purpose: Transplanting kidneys small for the recipient’s size results in inferior renal graft function. Body surface area (BSA) is related to kidney size. We used…2021 American Transplant Congress
Experiential Expertise: What Can Patients and Donors Teach Us About Living Donation?
*Purpose: While educational materials and discussions with medical professionals are factually sound, insight from actual living donors (LDs) and recipients (Rs) may offer unique, experiential…2021 American Transplant Congress
An Unexpected Case of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Overlooked Pretransplant, but Then Diagnosed Early After Kidney Transplant with a Negative Patient Outcome: A Case Report
UPMC Pinnacle Transplant, Harrisburg, PA
*Purpose: ATTR-CM is underrecognized and commonly overlooked and undiagnosed. When found it is often a late diagnosis in patients with severe left ventricular hypertrophy (LVH)…2021 American Transplant Congress
Alemtuzumab vs Antithymocyte Globulin Induction in Hepatitis C Viremic Donors to Hepatis C Negative Kidney Transplant Recipients
University of North Carolina Medical Center, Chapel Hill, NC
*Purpose: The optimal induction agent for kidney transplantation of hepatitis C virus nucleic acid test positive donors to negative recipients (HCV NAT D+/R-) is unknown.…2021 American Transplant Congress
Creatinine Reduction Ratio at 2 Postoperative Day as a Predicting Factor of Long-Term Outcomes After Living Donor Kidney Transplantation
*Purpose: Creatinine reduction ratio from 1 to 2 postoperative days (CRR2) under 30% has been defined as a slow graft function (SGF) and used to…
- « Previous Page
- 1
- …
- 87
- 88
- 89
- 90
- 91
- …
- 531
- Next Page »